The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola
暂无分享,去创建一个
John-Arne Røttingen | Ira M. Longini | Sema Mandal | Matthias Egger | Natalie E. Dean | W. John Edmunds | Ana Maria Henao-Restrepo | Conall H. Watson | Anton Camacho | Sven Trelle | Ximena Riveros | Miles W. Carroll | M. Egger | N. Dean | W. Edmunds | I. Longini | A. Camacho | M. Carroll | J. Røttingen | S. Keita | S. Trelle | M. Doumbia | A. Henao-Restrepo | G. Enwere | S. Hossmann | S. Mandal | G. Norheim | X. Riveros | A. Vicari | C. Watson | Moussa Doumbia | Godwin Enwere | Yper Hall | Stefanie Hossmann | Sakoba Keita | Mandy Kader Kondé | Gunnstein Norheim | Andrea S Vicari | Sara Sofie Viksmoen Watle | S. Watle | Y. Hall | M. K. Konde | Stefanie Hossmann
[1] C. Legrand,et al. Adjusting for centre heterogeneity in multicentre clinical trials with a time‒to‒event outcome , 2014, Pharmaceutical statistics.
[2] Peter F. Thall,et al. Recent Advances in Clinical Trial Design and Analysis , 1995, Cancer Treatment and Research.
[3] David Moher,et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials , 2013, BMJ.
[4] Mirjam Kretzschmar,et al. Ring Vaccination and Smallpox Control , 2004, Emerging infectious diseases.
[5] G. Piaggio,et al. Consort 2010 statement: extension to cluster randomised trials , 2012, BMJ : British Medical Journal.
[6] Martin Eichner,et al. Case isolation and contact tracing can prevent the spread of smallpox. , 2003, American journal of epidemiology.
[7] F. Fenner. Smallpox and its eradication , 1988 .
[8] D. Altman,et al. CONSORT statement: extension to cluster randomised trials , 2004, BMJ : British Medical Journal.
[9] Allan Donner,et al. Design and Analysis of Cluster Randomization Trials in Health Research , 2001 .
[10] W. Team. Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward Projections , 2014 .
[11] W. Edmunds,et al. Potential for large outbreaks of Ebola virus disease , 2014, Epidemics.
[12] D. Torgerson,et al. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals , 2003, BMJ : British Medical Journal.
[13] O. Aalen,et al. Survival and Event History Analysis: A Process Point of View , 2008 .
[14] Fredson Kuti-George,et al. Contact Tracing during an Outbreak of Ebola Virus Disease in the Western Area Districts of Sierra Leone: Lessons for Future Ebola Outbreak Response , 2016, Front. Public Health.
[15] Mikiko Senga,et al. Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. , 2014, The New England journal of medicine.
[16] Mark Chang,et al. Adaptive Design Methods in Clinical Trials , 2006 .
[17] D. Mohammadi. Ebola vaccine trials back on track , 2015, The Lancet.
[18] G. Rodier,et al. Ebola vaccines: keep the clinical trial protocols on the shelf and ready to roll out , 2015, The Lancet.
[19] M E Halloran,et al. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. , 1997, American journal of epidemiology.
[20] D L DeMets,et al. The alpha spending function approach to interim data analyses. , 1995, Cancer treatment and research.
[21] D. Ashby,et al. Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. , 2006, International journal of epidemiology.